معرفی
Murray Baker is a Professor and Senior Honorary Research Fellow at the School of Molecular Sciences, The University of Western Australia. His research focuses on organometallic chemistry, particularly gold-NHC complexes for biomedical applications. He teaches undergraduate chemistry courses including Structural Determination and Physical Chemistry, and Modern Organic Synthesis.
Education:
- Bachelor of Science with Honours (University Medal), University of Sydney
- PhD in Organic Chemistry, University of Sydney
Dr. Baker's research spans multiple areas of chemistry with a strong emphasis on organometallic compounds. His work on N-heterocyclic carbene (NHC) complexes, particularly gold-based compounds, has significant implications for cancer therapy and antimicrobial applications. He investigates the synthesis, structure, and biological activity of these compounds using advanced techniques including NMR spectroscopy and X-ray diffraction. His research bridges chemistry, materials science, and biomedical applications, contributing to sustainable development goals related to good health and well-being.
Recent publications show a clear trend toward developing gold-NHC complexes with enhanced anticancer properties and creating novel biomaterials for dental applications. His work combines synthetic chemistry with practical biomedical solutions, particularly in cancer therapy and periodontal disease treatment. The research demonstrates strong interdisciplinary collaboration between chemists, pharmacologists, and dental researchers.
Research Leadership:
- Principal Investigator on 28 research grants totaling millions in funding
- Lead researcher on antimicrobial hydrogel development for dental applications
- Collaborator on national drug discovery initiatives
Dr. Baker has supervised numerous graduate students and leads a research group focused on organometallic chemistry and its biomedical applications. His laboratory collaborates extensively with researchers across Australia and internationally, particularly in the development of novel therapeutic agents and biomaterials.
